Executive leadership for consequential moments.

Dr. Andrew F. McCoy is a healthcare executive, board leader, and portfolio-company operator with more than 30 years of experience leading growth, transformation, and enterprise performance across healthcare services, diagnostics, clinical trials, specialty services, and life sciences.

Throughout his career, Dr. McCoy has served in senior executive and board roles across a broad range of healthcare environments — from large integrated health systems and national diagnostic platforms to specialty-care organizations, clinical-research enterprises, and life-sciences companies. His work has consistently focused on the intersection of strategy, governance, operating performance, and leadership capability.

Dr. McCoy has led and supported complex value-creation initiatives including enterprise growth strategies, operational transformations, M&A integrations, divestitures, and carve-outs. He brings a board-level perspective combined with practical operating experience — an orientation that allows him to engage credibly with investors, directors, and executive teams on the decisions that matter most.

He is the founder and principal of A.M. Equity Partners LLC, a parent holding and operating platform that brings together selected advisory, leadership, learning, and intellectual-property initiatives. Through this platform, Dr. McCoy advises boards and executive teams, leads the METIS Leadership Lab, and advances The Neuroplastic Leader — a research-grounded platform exploring the neuroscience of adaptive leadership and organizational resilience.

Dr. McCoy's work is informed by a deep commitment to neuroscience-informed leadership — the application of behavioral science and cognitive principles to strengthen decision quality, organizational capability, and sustained performance. This thread runs through his advisory work, his writing, and the learning platforms he has developed.